Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05723081 · ClinicalTrials.gov registry record

Oklahoma Study of Native American Pain Risk III: Stress and Resilience

A clinical trial of Pain and Discrimination, Racial, sponsored by University of Oklahoma.

Recruiting
Registry status
220
Enrollment target
1
Study location

NCT05723081: Recruiting study of Pain and Discrimination, Racial, sponsored by University of Oklahoma.

NCT05723081 is a study of Pain and Discrimination, Racial that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 220 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05723081, a study of Pain and Discrimination, Racial, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
220 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about the relationship between environmental structural racism and discrimination and chronic pain risk in Native American adults. The main questions it aims to answer are: 1. How does environmental structural racism and discrimination affect chronic pain-promoting mechanisms in Native Americans? 2. What psychosocial factors buffer the negative effects of environmental structural racism and discrimination on chronic pain-promoting mechanisms?

Primary Outcome

Pain inhibition will be assessed using a conditioned pain modulation task with cold water as the conditioning stimulus and electric stimulations as the test stimulus.

Study Locations (1)

Oklahoma

  • University of Oklahoma - Schusterman Center - Tulsa

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2023-02-03
Est. Completion 2027-03-31
University of Oklahoma

358 total trials

What NCT05723081 shows while recruiting

NCT05723081 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (28% lower).

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.

NCT05723081 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05723081 about?

NCT05723081 is a clinical study titled "Oklahoma Study of Native American Pain Risk III: Stress and Resilience". The goal of this observational study is to learn about the relationship between environmental structural racism and discrimination and chronic pain risk in Native American adults. The main questions it aims to answer are: 1. How does environmental structural racism and discrimination affect chronic...

What is the current status of trial NCT05723081?

This trial is currently recruiting. The enrollment target is 220 participants. The study started on 2023-02-03. Estimated completion is 2027-03-31.

What conditions does trial NCT05723081 study?

This clinical trial studies the following conditions: Pain, Discrimination, Racial, Stress Physiology.

Who is sponsoring clinical trial NCT05723081?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05723081 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05723081's enrollment target sits among peer trials

220 81st of 374 higher than 294 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05723081, the US trial registry maintained by the National Library of Medicine. NCT05723081 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.